Up-to-date information on medicinal products is available on the website of the Scientific Centre for Expert Evaluation of Medicinal Products or on the State Register of Medicines portal.
Important! Medicinal products containing valproic acid have teratogenic potential (they may harm the unborn child if used by pregnant patients or by male patients within 3 months prior to conception). To ensure the correct use of medicinal products, informational materials have been developed for healthcare professionals and patients:
The information on this website is intended for healthcare professionals, representatives of medicinal product manufacturers, and representatives of pharmaceutical and medical companies.
This website is under the jurisdiction of the Russian Federation; accordingly, the information on this site is not intended for users from other countries whose legislation may require compliance with different rules regarding information, including its dissemination, collection, and processing. By continuing to use this website, you confirm that you are under the jurisdiction of the Russian Federation.